508 related articles for article (PubMed ID: 33245332)
1. Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial.
Hoekman DR; Vlieger AM; Stokkers PC; Mahhmod N; Rietdijk S; de Boer NK; de Meij TG; Frankenhuis C; D'Haens GR; Benninga MA
J Crohns Colitis; 2021 Jul; 15(7):1106-1113. PubMed ID: 33245332
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial: predictive factors for response to gut-directed hypnotherapy for refractory irritable bowel syndrome, a post hoc analysis.
Devenney J; Hasan SS; Morris J; Whorwell PJ; Vasant DH
Aliment Pharmacol Ther; 2024 Jan; 59(2):269-277. PubMed ID: 37927144
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial.
Flik CE; Laan W; Zuithoff NPA; van Rood YR; Smout AJPM; Weusten BLAM; Whorwell PJ; de Wit NJ
Lancet Gastroenterol Hepatol; 2019 Jan; 4(1):20-31. PubMed ID: 30473202
[TBL] [Abstract][Full Text] [Related]
4. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial.
Moser G; Trägner S; Gajowniczek EE; Mikulits A; Michalski M; Kazemi-Shirazi L; Kulnigg-Dabsch S; Führer M; Ponocny-Seliger E; Dejaco C; Miehsler W
Am J Gastroenterol; 2013 Apr; 108(4):602-9. PubMed ID: 23419384
[TBL] [Abstract][Full Text] [Related]
5. A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study).
Flik CE; van Rood YR; Laan W; Smout AJ; Weusten BL; Whorwell PJ; de Wit NJ
BMC Gastroenterol; 2011 Dec; 11():137. PubMed ID: 22185606
[TBL] [Abstract][Full Text] [Related]
6. Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease.
Peters SL; Muir JG; Gibson PR
Aliment Pharmacol Ther; 2015 Jun; 41(11):1104-15. PubMed ID: 25858661
[TBL] [Abstract][Full Text] [Related]
7. Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome.
Lövdahl J; Törnblom H; Ringström G; Palsson OS; Simrén M
Aliment Pharmacol Ther; 2022 Jun; 55(12):1501-1511. PubMed ID: 35505463
[TBL] [Abstract][Full Text] [Related]
8. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial.
Vlieger AM; Menko-Frankenhuis C; Wolfkamp SC; Tromp E; Benninga MA
Gastroenterology; 2007 Nov; 133(5):1430-6. PubMed ID: 17919634
[TBL] [Abstract][Full Text] [Related]
9. Intestinal Microbiome in Irritable Bowel Syndrome before and after Gut-Directed Hypnotherapy.
Peter J; Fournier C; Keip B; Rittershaus N; Stephanou-Rieser N; Durdevic M; Dejaco C; Michalski M; Moser G
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30453528
[TBL] [Abstract][Full Text] [Related]
10. Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome.
Lindfors P; Ljótsson B; Bjornsson E; Abrahamsson H; Simrén M
Neurogastroenterol Motil; 2013 Feb; 25(2):169-e86. PubMed ID: 23051178
[TBL] [Abstract][Full Text] [Related]
11. Gut-directed hypnotherapy in children with irritable bowel syndrome or functional abdominal pain (syndrome): a randomized controlled trial on self exercises at home using CD versus individual therapy by qualified therapists.
Rutten JM; Vlieger AM; Frankenhuis C; George EK; Groeneweg M; Norbruis OF; Tjon a Ten W; Van Wering H; Dijkgraaf MG; Merkus MP; Benninga MA
BMC Pediatr; 2014 Jun; 14():140. PubMed ID: 24894077
[TBL] [Abstract][Full Text] [Related]
12. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients.
Miller V; Carruthers HR; Morris J; Hasan SS; Archbold S; Whorwell PJ
Aliment Pharmacol Ther; 2015 May; 41(9):844-55. PubMed ID: 25736234
[TBL] [Abstract][Full Text] [Related]
13. Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials.
Lindfors P; Unge P; Arvidsson P; Nyhlin H; Björnsson E; Abrahamsson H; Simrén M
Am J Gastroenterol; 2012 Feb; 107(2):276-85. PubMed ID: 21971535
[TBL] [Abstract][Full Text] [Related]
14. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.
Gracie DJ; Williams CJ; Sood R; Mumtaz S; Bholah MH; Hamlin PJ; Ford AC
Clin Gastroenterol Hepatol; 2017 Mar; 15(3):376-384.e5. PubMed ID: 27189912
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission.
Hoekman DR; Zeevenhooven J; D'Haens GR; Benninga MA
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1086-1090. PubMed ID: 28639969
[TBL] [Abstract][Full Text] [Related]
16. Hypnotherapy for treatment of irritable bowel syndrome.
Webb AN; Kukuruzovic RH; Catto-Smith AG; Sawyer SM
Cochrane Database Syst Rev; 2007 Oct; (4):CD005110. PubMed ID: 17943840
[TBL] [Abstract][Full Text] [Related]
17. Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.
Perera LP; Radigan M; Guilday C; Banerjee I; Eastwood D; Babygirija R; Massey BT
Dig Dis Sci; 2019 Jul; 64(7):1923-1928. PubMed ID: 30725303
[TBL] [Abstract][Full Text] [Related]
18. Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 12 months of longitudinal follow-up.
Barberio B; Fairbrass KM; Gracie DJ; Ford AC
Neurogastroenterol Motil; 2024 Feb; 36(2):e14713. PubMed ID: 37994228
[TBL] [Abstract][Full Text] [Related]
19. Randomised controlled trial of brief intervention with biofeedback and hypnotherapy in patients with refractory irritable bowel syndrome.
Dobbin A; Dobbin J; Ross SC; Graham C; Ford MJ
J R Coll Physicians Edinb; 2013; 43(1):15-23. PubMed ID: 23516685
[TBL] [Abstract][Full Text] [Related]
20. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome.
Peters SL; Yao CK; Philpott H; Yelland GW; Muir JG; Gibson PR
Aliment Pharmacol Ther; 2016 Sep; 44(5):447-59. PubMed ID: 27397586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
